Caspr2 Antibodies in Patients with Thymomas

Total Page:16

File Type:pdf, Size:1020Kb

Caspr2 Antibodies in Patients with Thymomas View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector MALIGNANCIES OF THE THYMUS Caspr2 Antibodies in Patients with Thymomas Angela Vincent, FRCPath,* and Sarosh R. Irani, MA* neuromuscular junction. Neuromyotonia (NMT) is due to Abstract: Myasthenia gravis is the best known autoimmune disease motor nerve hyperexcitability that leads to muscle fascicula- associated with thymomas, but other conditions can be found in tions and cramps. A proportion of patients have antibodies patients with thymic tumors, including some that affect the central that appear to be directed against brain tissue-derived volt- nervous system (CNS). We have become particularly interested in age-gated potassium channels (VGKCs) that control the ax- patients who have acquired neuromyotonia, the rare Morvan disease, onal membrane potential.4,5 VGKC antibody titers are rela- or limbic encephalitis. Neuromyotonia mainly involves the periph- tively low in NMT. eral nerves, Morvan disease affects both the peripheral nervous Morvan disease is a rare condition first described in system and CNS, and limbic encephalitis is specific to the CNS. 1876 but until recently hardly mentioned outside the French Many of these patients have voltage-gated potassium channel auto- literature.6 The patients exhibit NMT plus autonomic distur- antibodies. All three conditions can be associated with thymomas bance (such as excessive sweating, constipation, and cardiac and may respond to surgical removal of the underlying tumor arrhythmias) and central nervous system (CNS) involvement together with immunotherapies and symptomatic treatments. Herein, that includes insomnia and confusion. Many reported cases we review the results of our recent studies that show that voltage- are associated with thymomas,7,8 although other tumors have gated potassium channel autoantibodies are not principally directed been identified.9 Morvan disease can also be nonparaneoplas- against the potassium channels themselves but in some patients are tic10 and occasionally self-limiting.11 Antibodies to VGKCs directed against a protein that is complexed with potassium channels have been found at moderately high titers in a few reported in both the peripheral nervous system and CNS, contactin-2 associ- cases of MoS.9 ated protein (Caspr2). These antibodies are common in the subgroup Limbic encephalitis (LE) was first described in the of patients with thymic malignancies. 1960s12 in association with small cell lung cancer. LE pa- tients develop a subacute onset of amnesia, which is often Key Words: Thymoma, VGKC antibody, VGKC complex, Neuro- profound, and is usually accompanied by seizures and psy- myotonia, Caspr2. chiatric disturbances. Patients traditionally have magnetic (J Thorac Oncol. 2010;5: S277–S280) resonance imaging evidence of inflammation within the me- dial temporal lobes. Although originally considered a para- neoplastic condition,13 there are increasing numbers of pa- he presence of autoantibodies to proteins that are shared tients with nonparaneoplastic LE, and many of these have Tbetween tumors and the nervous system is well known. VGKC antibodies at high titers.14–16 A relatively specific Such paraneoplastic or “onconeural” antibodies are usually feature in these cases is the presence of a serum hyponatre- directed at intracellular proteins and are unlikely, therefore, to mia. The VGKC antibody titers fall when the patients are be pathogenic, but the detection of the antibody helps identify treated in parallel with clinical improvements. the presence of a tumor. In thymomas, such antibodies NMT, MoS, and LE have all been described in patients 17,18 include those against titin in myasthenia gravis (MG)1 and with MG and thymoma, and in patients with thymoma 18 against a variety of neuronal antigens such as Hu and CV2/ without MG, usually with VGKC antibodies. These condi- CRMP5 in other cases.2 tions can also occur with other tumors (principally small cell By contrast, autoantibodies that are causative are usu- lung cancer) and other antibodies, but in this study, we will ally directed toward membrane receptors or ion channels. only discuss the patients with VGKC antibodies and review MG is caused in most patients by antibodies to acetylcholine recent data on the specificity of antibodies to VGKCs. receptors (AChRs3) that lead to loss of AChRs from the MATERIALS AND METHODS *Department of Clinical Neurology, John Radcliffe Hospital, Oxford, United The data and methods are based on the results of studies Kingdom. Disclosure: Angela Vincent, FRCPath, and her department receive royalties over a number of years, which are described in detail in Ref. and payments for antibody assays. 19. Patient serum samples were mainly referred for testing by Address for correspondence: Angela Vincent, FRCPath, Department of our clinical neuroimmunology service, and the clinical fea- Clinical Neurology, Level 6 West Wing, John Radcliffe Hospital, Oxford tures were obtained subsequently by questionnaires and dis- OX3 9DU, UK. E-mail: [email protected] cussion with the referring neurologists. VGKC antibodies Copyright © 2010 by the International Association for the Study of Lung 125 Cancer were measured by radioimmunoprecipitation of I-␣-dend- ISSN: 1556-0864/10/0510-0277 rotoxin-labeled VGKCs extracted from rabbit brain tissue.4,5 Journal of Thoracic Oncology • Volume 5, Number 10, Supplement 4, October 2010 S277 Vincent and Irani Journal of Thoracic Oncology • Volume 5, Number 10, Supplement 4, October 2010 The brain tissue extracts were made in 2% digitonin, a Of the 82 patients to be described, 61 had LE, 5 had detergent which is mild and does not dissociate protein MoS, and 16 had NMT. Six patients had thymomas including complexes. Some experiments were performed with addi- one patient with MoS and five with NMT; one patient with tional sodium dodecyl sulfate (SDS), a harsher detergent. We NMT had a metastatic endometrial carcinoma. The thymoma also transfected human embryonic kidney cells (HEK293) classifications were obtained from the patients’ clinical records cells with cDNAs for VGKC subunits (Kv1.1, 1.2, 1.6) or and are given in Table 1. Eight of the remaining patients had past contactin-2 associated protein (Caspr2) or Caspr2-EGFP. The histories of other tumors that appeared to be inactive at the time latter construct was made by fusing the cDNA for EGFP onto of presentation of their VGKC-Ab–related diseases (five LE, the C-terminal end of the Caspr2 (see Ref. 19). one MoS, and two NMT, see Ref. 19). The results of their VGKC antibodies are shown in RESULTS Figure 1A; as expected from observations on smaller cohorts The patients to be discussed here were chosen on the or individual cases, those with NMT had relatively low basis of their high VGKC-Abs (values Ͼ400 pM; normal antibodies compared with those with LE, whereas the few values Ͻ100 pM), because patients with high titers most MoS cases had intermediate titers. Correspondingly, the an- often have CNS disease. We will compare those patients with tibody titers in the patients with thymomas were lower than in thymomas or other tumors with those who did not have those without (Figure 1B). detectable tumors. It should be made clear, therefore, that A series of experiments were undertaken to define the many patients with thymomas and antibody-mediated dis- specificities of the antibodies for the VGKCs. The VGKCs 125 ␣ eases, e.g., MG, do not have VGKC antibodies and would not that bind I- -dendrotoxin and are used for measuring have been studied nor did we include patients with lower antibodies are tetramers composed of differing proportions of VGKC-Ab titers. Kv1.1, 1.2, 1.4, and 1.6. However, when we expressed these Kv1 subunits individually or collectively in human embry- onic kidney (HEK293) cells, we could not detect Kv1- specific binding by immunofluorescence, a technique that we TABLE 1. Thymoma Types in Patients with Thymoma and now use for detecting antibodies to many other membrane VGKC Antibodies antigens such as the AChR (termed a cell-based assay; as in Description of Thymoma Refs. 19–22). Moreover, there was no effect of the antibodies Sex Age from Histology Reports from patients with high titers of VGKC antibodies on the M 71 Type B3, Stage 2 voltage-dependent currents in these cells (See Ref. 19). M 60 Type B2, Stage 2 We hypothesized that the antibodies might be binding, F 53 Thymic carcinoma, Type B2, Stage 2 instead, to other proteins that were part of the brain mem- M 37 Type AB brane protein complexes that contain VGKCs. To investigate M 49 Malignant metastatic thymoma this, we first added increasing amounts of harsh detergent, M 44 Malignant metastatic thymoma SDS, to the VGKC assays. Although the binding of commer- F 74 Malignant metastatic thymoma, Type B2 with areas of B3 cial antibodies to Kv1.1 or 1.2 was not substantially affected by 0.025% SDS, binding of the patients’ antibodies was MG, myasthenia gravis. reduced to approximately 20% (Figure 1C). This suggested FIGURE 1. A, Voltage-gated potassium channel antibody (VGKC-Ab) titers in healthy controls (HCs) and in neuromyotonia (NMT), Morvan dis- ease (MoS), and limbic encephalitis (LE) patients. B, VGKC-Ab titers in patients with and without thymomas. C, The binding sites for patients’ anti- bodies on 125I ␣-dendrotoxin-labeled digitonin- solubilized VGKC antibody complexes are more sensitive to a low concentration of sodium dode- cyl sulfate (SDS) than binding sites for Kv1.1 anti- bodies. D, Healthy control sera (HC) do not show binding to the surface of human embryonic kid- ney cells expressing Caspr2. The Caspr2 was tagged with enhanced green fluorescent protein (Caspr2-EGFP) so that the transfected cells could be identified. Some VGKC-Ab positive sera (1:100 dilution), including six of the seven sera from pa- tients with thymomas, bound to Caspr2-trans- fected cells. S278 Copyright © 2010 by the International Association for the Study of Lung Cancer Journal of Thoracic Oncology • Volume 5, Number 10, Supplement 4, October 2010Caspr2 Antibodies in Patients with Thymomas that the SDS had dissociated the target of the patients’ TABLE 3.
Recommended publications
  • Central Pain in the Face and Head
    P1: KWW/KKL P2: KWW/HCN QC: KWW/FLX T1: KWW GRBT050-128 Olesen- 2057G GRBT050-Olesen-v6.cls August 17, 2005 2:10 ••Chapter 128 ◗ Central Pain in the Face and Head J¨orgen Boivie and Kenneth L. Casey CENTRAL PAIN IN THE FACE AND HEAD Anesthesia dolorosa denotes pain in a region with de- creased sensibility after lesions in the CNS or peripheral International Headache Society (IHS) code and diag- nervous system (PNS). The term deafferentation pain is nosis: used for similar conditions, but it is more commonly used in patients with lesions of spinal nerves. 13.18.1 Central causes of facial pain 13.18.1 Anesthesia dolorosa (+ code to specify cause) 13.18.2 Central poststroke pain EPIDEMIOLOGY 13.18.3 Facial pain attributed to multiple sclerosis 13.18.4 Persistent idiopathic facial pain The prevalence of central pain varies depending on the un- 13.18.5 Burning mouth syndrome derlying disorder (Tables 128-1 and 128-2) (7,29). In the ab- 13.19 Other centrally mediated facial pain (+ code to sence of large scale epidemiologic studies, only estimates specify etiology) of central pain prevalence can be quoted. In the only prospective epidemiologic study of central Note that diagnosis with IHS codes 13.18.1, 13.18.4, and pain, 191 patients with central poststroke pain (CPSP) 13.18.5 may have peripheral causes. were followed for 12 months after stroke onset (1). Sixteen World Health Organization (WHO) code and diagnosis: (8.4%) developed central pain, an unexpectedly high inci- G 44.810 or G44.847.
    [Show full text]
  • Neurosyphilis Presenting with Myelitis-Case Series and Literature Review
    Neurosyphilis presenting with myelitis-Case series and literature review Yali Wu Capital Medical University Aliated Beijing Ditan Hospital https://orcid.org/0000-0002-9737-6439 Wenqing Wu ( [email protected] ) https://orcid.org/0000-0001-7428-5529 Case report Keywords: Syphilis, Neurosyphilis, Spinal cord, Magnetic resonance imaging Posted Date: April 5th, 2019 DOI: https://doi.org/10.21203/rs.2.1849/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Version of Record: A version of this preprint was published at Journal of Infection and Chemotherapy on February 1st, 2020. See the published version at https://doi.org/10.1016/j.jiac.2019.09.007. Page 1/9 Abstract Background Neurosyphilis is a great imitator because of its various clinical symptoms. Syphilitic myelitis is extremely rare manifestation of neurosyphilis and often misdiagnosed. However, a small amount of literature in the past described its clinical manifestations and imaging features, and there was no relevant data on the prognosis, especially the long-term prognosis. In this paper, 4 syphilis myelitis patients admitted to our hospital between July 2012 and July 2017 were retrospectively reviewed. In the 4 patients, 2 were females, and 2 were males. We present our experiences with syphilitic myelitis, discuss the characteristics, treatment and prognosis. Case presentation The diagnosis criteria were applied: (1) diagnosis of myelitis established by two experienced neurologist based on symptoms and longitudinally extensive transverse myelitis (LETM) at the cervical and thoracic levels mimicked neuromyelitis optic (NMO) on magnetic resonance imaging (MRI) ; (2) Neurosyphilis (NS) was diagnosed by positive treponema pallidum particle assay (TPPA) and toluidine red untreated serum test (TRUST) in the serum and CSF; (3) negative human immunodeciency virus (HIV).
    [Show full text]
  • Autoimmune Neurological Disorders - Does the Age Matter?
    1 Autoimmune neurological disorders - does the age matter? Yael Hacohen1,2 and Angela Vincent3 1. Department of Paediatric Neurology, Great Ormond Street Hospital for Children, London, 2. Department of Neuroinflammation, Queen Square MS Centre, UCL Institute of Neurology, London. 3. Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford. Antibodies binding to central nervous system (CNS) channels, receptors and other synaptic or glial proteins are now recognised as a likely cause of neurological disorders in both adults and children (see Table). Autoimmune encephalopathies are characterized variously by impaired alertness, amnesia, seizures, movement disorders, psychiatric features or autonomic instability, but without focal neurological deficits. The neuronal cell-surface antigens are essential to cellular function or neurotransmission and are generally expressed throughout the nervous system1. Autoimmune forms of demyelinating disorders, by contrast, can present as optic neuritis, transverse myelitis or a range of CNS presentations reflecting the site of the lesions. The glial (myelin or astrocyte) cell-surface antigens are widely expressed throughout the CNS. All these patients frequently respond well to immunotherapies, and in some cases the disorders are monophasic and do not require long-term immunosuppression2. By contrast, the typical paraneoplastic antibodies are generated against tumour antigens that are shared with the nervous system, and are usually associated with T cell-mediated pathogenic mechanisms; the antibodies represent an epiphenomenon of the disease but can be useful biomarkers for the existence of the appropriate tumour. Unfortunately, patients with the intracellular antibodies often progress relentlessly and do not respond to immunotherapies3. The strongest levels of evidence linking identified cell surface antibodies to the pathology of specific disorders are found with AQP4 antibody in neuromyelitis optica spectrum disorder and NMDAR antibody in NMDAR-antibody encephalitis.
    [Show full text]
  • Transverse Myelitis After Diphtheria, Tetanus, and Polio Immunisation
    1450 BRITISH MEDICAL JOURNAL 4 JUNE 1977 The patient recovered completely and was treated with co-trimoxazole to the umbilicus. Sensation to pinprick was absent up to the level of T4 5; 3 tablets twice daily for a further six months. At six months x-ray examina- at this level the child cried and tried to push the pin away. The power, tone, tion showed sclerosis of the right sacroiliac joint and irregularities of the and reflexes in her arms were normal and the cranial nervcs were normal. joint margins. All other systems were normal. Br Med J: first published as 10.1136/bmj.1.6074.1450 on 4 June 1977. Downloaded from Initial investigations showed a white cell count of 16-2 109 1(16 200 mm:, with 58 °, lymphocytes and 34 ",, mature neutrophils. Her cerebrospinal Comment fluid (CSF) was clear and tunder pressure of 160 mm of watcr. It contained four polymorphs, tw!o lymphocytes, two red cells, and a protein concentra- This case illustrates the facts, well-recognised by microbiologists, tion of 0-3 g 1 (30 mg 100 ml). A myelogram gave a normal result. Virology that most salmonella serotypes may invade the blood stream and that of the CSF and throat showed nothing abnormal. Poliovirus type 2 was systemic disease need not be preceded by gastrointestinal isolated from the stools. symptoms,' Shc was started on dexamethasone 1 mg four times daily for four days, nor need the patient have an overt susceptibility to bacteraemia. followed by prednisolone 5 mg three times daily continued for a six xeek Acute suppurative arthritis or osteomyelitis is usually due to Staphy- period.
    [Show full text]
  • ICD9 & ICD10 Neuromuscular Codes
    ICD-9-CM and ICD-10-CM NEUROMUSCULAR DIAGNOSIS CODES ICD-9-CM ICD-10-CM Focal Neuropathy Mononeuropathy G56.00 Carpal tunnel syndrome, unspecified Carpal tunnel syndrome 354.00 G56.00 upper limb Other lesions of median nerve, Other median nerve lesion 354.10 G56.10 unspecified upper limb Lesion of ulnar nerve, unspecified Lesion of ulnar nerve 354.20 G56.20 upper limb Lesion of radial nerve, unspecified Lesion of radial nerve 354.30 G56.30 upper limb Lesion of sciatic nerve, unspecified Sciatic nerve lesion (Piriformis syndrome) 355.00 G57.00 lower limb Meralgia paresthetica, unspecified Meralgia paresthetica 355.10 G57.10 lower limb Lesion of lateral popiteal nerve, Peroneal nerve (lesion of lateral popiteal nerve) 355.30 G57.30 unspecified lower limb Tarsal tunnel syndrome, unspecified Tarsal tunnel syndrome 355.50 G57.50 lower limb Plexus Brachial plexus lesion 353.00 Brachial plexus disorders G54.0 Brachial neuralgia (or radiculitis NOS) 723.40 Radiculopathy, cervical region M54.12 Radiculopathy, cervicothoracic region M54.13 Thoracic outlet syndrome (Thoracic root Thoracic root disorders, not elsewhere 353.00 G54.3 lesions, not elsewhere classified) classified Lumbosacral plexus lesion 353.10 Lumbosacral plexus disorders G54.1 Neuralgic amyotrophy 353.50 Neuralgic amyotrophy G54.5 Root Cervical radiculopathy (Intervertebral disc Cervical disc disorder with myelopathy, 722.71 M50.00 disorder with myelopathy, cervical region) unspecified cervical region Lumbosacral root lesions (Degeneration of Other intervertebral disc degeneration,
    [Show full text]
  • Transverse Myelitis Interagency Collaboration
    SHNIC Specialized Health Needs Factsheet: Transverse Myelitis Interagency Collaboration What is it? Transverse Myelitis is a neurological disorder caused by inflammation of the spinal cord. A child will experience weakness, pain, sensory and autonomic dysfunction. Auto- nomic, involuntary activities such as breathing, digestion, heartbeat and reflexes can be affected. Symptoms can ap- pear suddenly within hours or progress over a span of sev- eral weeks. Approximately 25% of cases are children. A peak in incidence occurs between ages of 10 and 19 and females are at higher risk than men. During an inflammato- ry response the myelin, or protective fatty coating on nerve cells, is damaged or destroyed. TM can also be the first symptom to diagnose Multiple Sclerosis. What causes it? Researchers believe it is the body’s immune response, not the infection itself, that causes the inflammatory response. This indicates an auto-immune reaction, where the body attacks it’s own tissue rather than the infection, is responsible. Research has made connections to the damage of spinal nerves following a viral or bacterial infection, especially those associated with a rash. According to the National Institute of Neurologic Disorders and Stroke, infectious agents sus- pected of causing TM include Varicella zoster (the virus that causes chickenpox and shingles), Herpes simplex, Cytomegalovirus, Epstein-Barr, Influenza, Echovirus, Human immunodefi- ciency virus (HIV), Hepatitis A, and Rubella. In some cases, bacterial infections like a middle ear infection and bacterial pneumonia have also been linked. What are the symptoms? Symptoms can start slowly and progressively worsen over hours or days. Damage depends on the affected area of the spinal cord.
    [Show full text]
  • The Transverse Myelitis Association ...Advocating for Those with Acute Disseminated Encephalomyelitis, Neuromyelitis Optica, Optic Neuritis and Transverse Myelitis
    The Transverse Myelitis Association ...advocating for those with acute disseminated encephalomyelitis, neuromyelitis optica, optic neuritis and transverse myelitis ACUTE DISSEMINATED ENCEPHALOMYELITIS (ADEM) OVERVIEW Acute Disseminated Encephalomyelitis (ADEM) is a rare inflammatory demyelinating disease of the central nervous system. ADEM is thought to be an autoimmune disorder in which the body’s immune system mistakenly attacks its own brain tissue, triggered by an environmental stimulus in genetically susceptible individuals. More often it is believed to be triggered by a response to an infection or to a vaccination. For this reason, ADEM is sometimes referred to as post-infectious or post-immunization acute disseminated encephalomyelitis. EPIDEMIOLOGY According to a study published in 2008, the estimated incidence in California is 0.4 per 100,000 population per year, and there are approximately 3 to 6 ADEM cases seen each year at regional medical centers in the US, UK, and Australia2. ADEM is more common in children and adolescents than it is in adults, and there does not seem to be a higher incidence of ADEM among males or females, nor does there seem to be a higher frequency among any particular ethnic group. Post-infectious – In approximately 50-75 percent of ADEM cases, the inflammatory attack is preceded by a viral or bacterial infection. There have been a large number of viruses associated with these infections, including but not limited to: measles, mumps, rubella, varicella zoster, Epstein-Barr, cytomegalovirus, herpes simplex, hepatitis A, influenza, and enterovirus infections. A seasonal distribution has been observed showing that most ADEM cases occur in the winter and spring.
    [Show full text]
  • Inflammation of the Central Nervous System- Encephalitis, Myelitis, and Meningitis
    Inflammation of the Central Nervous System- Encephalitis, Myelitis, and Meningitis Stacy Dillard, DVM, Diplomate ACVIM (Neurology) Inflammation of the central nervous system is a very common condition seen in veterinary neurology. The area in which the inflammation predominates indicates which of the clinical syndromes we use to name the disease. Inflammation involving the brain is called encephalitis, of the spinal cord is called myelitis and of the meninges is called meningitis. It is common to have more than one area of the central nervous system affected and therefore combinations of the names are often used such as meningoencephalomyelitis or meningoencephalitis. Encephalitis is the most common area of the central nervous system to be affected and will be used as the general term in this article. Etiology There are two main classes of encephalitis: infectious and idiopathic. Infectious etiologies include viruses, fungi, bacteria, protozoa, tick borne diseases and even algae. True infectious encephalitis is much less common in the dog than in other species including humans; however diagnosis is critical for proper targeted therapy. Idiopathic encephalitis means that an infectious etiology has not been found and encompasses a wide range of syndromes appreciated in the canine patient. Many idiopathic encephalitidies are thought to be immune-mediated and respond well to immune-suppression. Other idiopathic encephalitis, such as necrotizing encephalitis found in young toy breed dogs, do not appear to respond as well to immuno- suppression and therefore may represent another form of the disease. Idiopathic encephalitis is much more common in the dog than infectious encephalitis; however, definitive diagnosis is critical as treatment is markedly different between the two categories of disease.
    [Show full text]
  • Syringomyelia and Arachnoiditis
    106 Journal of Neurology, Neurosurgery, and Psychiatry 1990;53:106-113 Syringomyelia and arachnoiditis L R Caplan, A B Norohna, L L Amico Abstract and weakness in his right hand. Months later, Five patients with chronic arachnoiditis he developed sensory loss and weakness of the and syringomyelia were studied. Three hands, more noticeable in the left than the patients had early life meningitis and right. Atrophy, frequent burns, and hand developed symptoms of syringomyelia tremor were reported by the patient. Four eight, 21, and 23 years after the acute years later, the lower extremities became weak, infection. One patient had a spinal dural initially on the right side. He then experienced thoracic AVM and developed a thoracic weakness in the left leg which soon became syrinx 11 years after spinal subarachnoid more severe than in the right. He complained of haemorrhage and five years after surgery a drawing, burning pain in both arms from the on the AVM. A fifth patient had tuber- hands to the radial forearms and from the hips culous meningitis with transient spinal to the toes. cord dysfunction followed by develop- In 1943 (aged 46), he was first evaluated at ment ofa lumbar syrinx seven years later. the Harvard Neurological Unit at Boston City Arachnoiditis can cause syrinx formation Hospital. There was diminished body hair and by obliterating the spinal vasculature burn scars on his fingers. Mental function and causing ischaemia. Small cystic regions cranial nerves were normal except for a slight of myelomalacia coalesce to form left lower facial droop and slighlt leftward cavities. In other patients, central cord protrusion of the tongue.
    [Show full text]
  • Paraneoplastic Neurological and Muscular Syndromes
    Paraneoplastic neurological and muscular syndromes Short compendium Version 4.5, April 2016 By Finn E. Somnier, M.D., D.Sc. (Med.), copyright ® Department of Autoimmunology and Biomarkers, Statens Serum Institut, Copenhagen, Denmark 30/01/2016, Copyright, Finn E. Somnier, MD., D.S. (Med.) Table of contents PARANEOPLASTIC NEUROLOGICAL SYNDROMES .................................................... 4 DEFINITION, SPECIAL FEATURES, IMMUNE MECHANISMS ................................................................ 4 SHORT INTRODUCTION TO THE IMMUNE SYSTEM .................................................. 7 DIAGNOSTIC STRATEGY ..................................................................................................... 12 THERAPEUTIC CONSIDERATIONS .................................................................................. 18 SYNDROMES OF THE CENTRAL NERVOUS SYSTEM ................................................ 22 MORVAN’S FIBRILLARY CHOREA ................................................................................................ 22 PARANEOPLASTIC CEREBELLAR DEGENERATION (PCD) ...................................................... 24 Anti-Hu syndrome .................................................................................................................. 25 Anti-Yo syndrome ................................................................................................................... 26 Anti-CV2 / CRMP5 syndrome ............................................................................................
    [Show full text]
  • Transverse Myelitis and Acute HIV Infection: a Case Report Paulo Andrade*, Cristóvão Figueiredo, Cláudia Carvalho, Lurdes Santos and António Sarmento
    Andrade et al. BMC Infectious Diseases 2014, 14:149 http://www.biomedcentral.com/1471-2334/14/149 CASE REPORT Open Access Transverse myelitis and acute HIV infection: a case report Paulo Andrade*, Cristóvão Figueiredo, Cláudia Carvalho, Lurdes Santos and António Sarmento Abstract Background: Most HIV infected patients will develop some sort of neurologic involvement of the disease throughout their lives, usually in advanced stages. Neurologic symptoms may occur in acute HIV infection but myelopathy in this setting is rare. Up until this date, only two cases of transverse myelitis as a manifestation of acute HIV infection have been reported in the literature. Therapeutic approach in these patients is not well defined. Case presentation: A 35 year-old male Caucasian recently returned from the tropics presented to our hospital with urinary retention and acute paraparesis. After extensive diagnostic workup he was diagnosed with acute HIV infection presenting as transverse myelitis. Full neurologic recovery was observed without the use of anti-retroviral therapy. Conclusion: Acute spinal cord disorders are challenging, as they present a wide array of differential diagnosis and may lead to devastating sequelae. Timely and rigorous diagnostic workup is of the utmost importance when managing these cases. Clinicians should be aware of the protean manifestations of acute HIV infection, including central nervous system involvement, and have a low threshold for HIV screening. Keywords: Transverse myelitis, HIV, Acute infection Background fever, poliomyelitis, typhoid fever and meningococcal dis- HIV-associated neurological syndromes are diverse and ease in advance. Excluding an episode of malaria soon usually diagnosed at advanced stages of the disease [1].
    [Show full text]
  • Transverse Myelitis
    TRANSVERSE MYELITIS Demyelinating Central Nervous System Disease WHAT IS TRANSVERSE MYELITIS? Transverse myelitis is an inflammation of both sides of one section of the spinal cord. This neurological disorder often damages the insulating material covering nerve cell fibers (myelin). Transverse myelitis interrupts the messages that the spinal cord nerves send throughout the body. This can cause pain, muscle weakness, paralysis, sensory problems, or bladder and bowel dysfunction. Possible causes of transverse myelitis may include infections and immune system disorders that attack the body's tissues. It could also be caused by other myelin disorders, such as multiple sclerosis. Treatment for transverse myelitis includes medications and rehabilitative therapy. Most people with transverse myelitis recover at least partially. Those with severe attacks sometimes are left with major disabilities. WHAT ARE THE SYMPTOMS? Typical signs and symptoms include: • Pain. Transverse myelitis pain may begin suddenly in your lower back. Sharp pain may shoot down your legs or arms or around your chest or abdomen. Pain symptoms vary based on the part of your spinal cord that's affected. • Abnormal sensations. Some people with transverse myelitis report sensations of numbness, tingling, coldness or burning. Some are especially sensitive to the light touch of clothing or to extreme heat or cold. You may feel as if something is tightly wrapping the skin of your chest, abdomen or legs. • Weakness in your arms or legs. Some people notice that they're stumbling or dragging one foot, or heaviness in the legs. Others may develop severe weakness or even total paralysis. • Bladder and bowel problems. This may include needing to urinate more frequently, urinary incontinence, difficulty urinating and constipation.
    [Show full text]